Negative regulation of B cell activation

pathway activity — cross-omics
GO:0050869Cross-omicsSHRNA → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of B cell activation pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Myeloma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are TM9SF2, SDHAF3, and CCDC34, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The box plot shows the strongest association, TM9SF2 grouped by Negative regulation of B cell activation-low versus -high activity in BLOOD_Myeloma.

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_MyelomaTM9SF2 →-0.963-1.438<.001.00225
LARGE_INTESTINESDHAF3 →+1.251+1.262<.001<.00134
KIDNEYCCDC34 →+0.739+1.095<.001<.00134
KIDNEYESPL1 →+0.992+1.270.006.00134
URINARY_TRACTRELA →+0.877+1.689.006<.00134
BONETUBGCP4 →+0.870+1.756.007<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

TM9SF2 by Negative regulation of B cell activation activity — BLOOD_Myeloma

Box plot of TM9SF2 in Negative regulation of B cell activation-low vs -high samples in BLOOD_Myeloma.

Explore this box plot interactively →

Exploration